Stay updated on Phase 1b Micellar Docetaxel in mCRPC Clinical Trial
Sign up to get notified when there's something new on the Phase 1b Micellar Docetaxel in mCRPC Clinical Trial page.

Latest updates to the Phase 1b Micellar Docetaxel in mCRPC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.8%
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check34 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check62 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check77 days agoChange DetectedThe webpage has been updated to include information about a new clinical trial for a micellar formulation of Docetaxel in patients with metastatic castration-resistant prostate cancer (mCRPC), while significant details about previous treatment methods and their drawbacks have been removed.SummaryDifference42%
- Check84 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to Phase 1b Micellar Docetaxel in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 1b Micellar Docetaxel in mCRPC Clinical Trial page.